Ooh La La… Retina! The Best of Day 2 at EURETINA 2025
From drug delivery wins to chatbot scribes, Day 2 in Paris proves retina science is très on point. As the…
Outlook Therapeutics Requests Type A Meeting with FDA After Second Rejection of Wet AMD Drug Bevacizumab
The road to U.S. approval for ONS-5010 has been anything but smooth. Outlook Therapeutics (New Jersey, USA) is once again…
latest posts
